MatthewGrayMcMenemyMD

Ophthalmology • Sugar Land, TX

Anterior Segment Related, Cataract Related, Glaucoma Related

President of Lone Star Eye Care, P.A.

Join to view full profile

Dr. McMenemy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McMenemy's full profile

Already have an account?

Office
3515 Town Center Blvd S
Sugar Land, TX 77479
Phone+1 281-277-8400

Fax+1 281-277-8408

Education & Training

University of Texas Health Science Center at HoustonResidency, Ophthalmology, 1987 - 1990
Memorial Hermann Health SystemResidency, Family Medicine, 1982 - 1984
McGovern Medical School at UTHealthClass of 1982

Certifications & Licensure

CA State Medical License 1990 - Present
TX State Medical License 1983 - 2026
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

48 citations
Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial
Sanjay Asrani, Alan L. Robin, Janet B. Serle, Richard A Lewis, Dale W Usner
American Journal of Ophthalmology. 2019-11-01
17 citations
Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma ...
Jess T. Whitson, Tony Realini, Quang H. Nguyen, Matthew McMenemy, Stephen M. Goode
Clinical Ophthalmology. 2013-06-06
30 citations
Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%.
Quang H. Nguyen, Matthew McMenemy, Tony Realini, Jess T. Whitson, Stephen M. Goode
Journal of Ocular Pharmacology and Therapeutics. 2013-04-01